Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Jan;40(1):139–144. doi: 10.1136/gut.40.1.139

Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis.

E H Forrest 1, I A Bouchier 1, P C Hayes 1
PMCID: PMC1027024  PMID: 9155592

Abstract

BACKGROUND: Adenosine is a potent vasoactive substance that may be responsible for mediating the altered haemodynamics found in patients with cirrhosis. AIM: The administration of oral theophylline was used to investigate the effect of adenosine receptor antagonism upon the circulation of patients with cirrhosis. METHODS: Twenty eight patients were given oral theophylline and intravascular haemodynamic measurements obtained over approximately one hour. RESULTS: After 240 mg of oral theophylline elixir the hepatic venous pressure gradient mean fell from 21.8 (2.1) to 19.9 (2.4) mm Hg (p < 0.01), and azygos blood flow fell from 481 (94) to 375 (83) ml/min (p < 0.05). There were no changes in cardiac output or systemic vascular resistance despite a fall in mean arterial pressure (92.2 (2.0) to 89.2 (1.8) mm Hg; p < 0.05) and a rise in heart rate (78.3 (3.0) to 82.4 (3.2); p < 0.001). Left renal vein flow measured by a reverse thermodilution catheter rose from 387 (91) to 601 (119) ml/ min (p < 0.05). The proportion of cardiac output perfusing the left kidney rose from 5.0 (1.3) to 9.7 (2.8)%. CONCLUSIONS: These changes indicate a significant role for adenosine in the renal vasoconstriction and a more minor role in the maintenance of portal hypertension.

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agmon Y., Dinour D., Brezis M. Disparate effects of adenosine A1- and A2-receptor agonists on intrarenal blood flow. Am J Physiol. 1993 Dec;265(6 Pt 2):F802–F806. doi: 10.1152/ajprenal.1993.265.6.F802. [DOI] [PubMed] [Google Scholar]
  2. Bernardi M., Santini C., Trevisani F., Baraldini M., Ligabue A., Gasbarrini G. Renal function impairment induced by change in posture in patients with cirrhosis and ascites. Gut. 1985 Jun;26(6):629–635. doi: 10.1136/gut.26.6.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biaggioni I., King L. S., Enayat N., Robertson D., Newman J. H. Adenosine produces pulmonary vasoconstriction in sheep. Evidence for thromboxane A2/prostaglandin endoperoxide-receptor activation. Circ Res. 1989 Dec;65(6):1516–1525. doi: 10.1161/01.res.65.6.1516. [DOI] [PubMed] [Google Scholar]
  4. Bruns R. F. Adenosine receptors. Roles and pharmacology. Ann N Y Acad Sci. 1990;603:211–226. doi: 10.1111/j.1749-6632.1990.tb37674.x. [DOI] [PubMed] [Google Scholar]
  5. CAESAR J., SHALDON S., CHIANDUSSI L., GUEVARA L., SHERLOCK S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 1961 Aug;21:43–57. [PubMed] [Google Scholar]
  6. Chasis H., Ranges H. A., Goldring W., Smith H. W. THE CONTROL OF RENAL BLOOD FLOW AND GLOMERULAR FILTRATION IN NORMAL MAN. J Clin Invest. 1938 Sep;17(5):683–697. doi: 10.1172/JCI100996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Churchill P. C., Bidani A. Renal effects of selective adenosine receptor agonists in anesthetized rats. Am J Physiol. 1987 Feb;252(2 Pt 2):F299–F303. doi: 10.1152/ajprenal.1987.252.2.F299. [DOI] [PubMed] [Google Scholar]
  8. Daval J. L., Nehlig A., Nicolas F. Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci. 1991;49(20):1435–1453. doi: 10.1016/0024-3205(91)90043-b. [DOI] [PubMed] [Google Scholar]
  9. Edlund A., Ohlsén H., Sollevi A. Renal effects of local infusion of adenosine in man. Clin Sci (Lond) 1994 Aug;87(2):143–149. doi: 10.1042/cs0870143. [DOI] [PubMed] [Google Scholar]
  10. Forrest E. H., Jones A. L., Dillon J. F., Walker J., Hayes P. C. The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. J Hepatol. 1995 Sep;23(3):254–258. doi: 10.1016/0168-8278(95)80468-4. [DOI] [PubMed] [Google Scholar]
  11. Grose R. D., Hayes P. C. Review article: the pathophysiology and pharmacological treatment of portal hypertension. Aliment Pharmacol Ther. 1992 Oct;6(5):521–540. doi: 10.1111/j.1365-2036.1992.tb00567.x. [DOI] [PubMed] [Google Scholar]
  12. Hartleb M., Moreau R., Cailmail S., Gaudin C., Lebrec D. Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. Gastroenterology. 1994 Oct;107(4):1085–1093. doi: 10.1016/0016-5085(94)90233-x. [DOI] [PubMed] [Google Scholar]
  13. Hasegawa M., Yamada S., Hirayama C. Fasting plasma caffeine level in cirrhotic patients: relation to plasma levels of catecholamines and renin activity. Hepatology. 1989 Dec;10(6):973–977. doi: 10.1002/hep.1840100614. [DOI] [PubMed] [Google Scholar]
  14. Hayes P. C., Terrace D., Peaston I., Bouchier I. A., Redhead D., Brash H. M. Computerised system for the continuous measurement of azygos venous blood flow. Gut. 1992 Mar;33(3):372–374. doi: 10.1136/gut.33.3.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hornych A., Brod J., Slechta V. The measurement of the renal venous outflow in man by the local thermodilution method. Nephron. 1971;8(1):17–32. doi: 10.1159/000179903. [DOI] [PubMed] [Google Scholar]
  16. Kew M. C., Brunt P. W., Varma R. R., Hourigan K. J., Williams H. S., Sherlock S. Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet. 1971 Sep 4;2(7723):504–510. doi: 10.1016/s0140-6736(71)90435-1. [DOI] [PubMed] [Google Scholar]
  17. Kiel J. W., Pitts V., Benoit J. N., Granger D. N., Shepherd A. P. Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats. Am J Physiol. 1985 Feb;248(2 Pt 1):G192–G195. doi: 10.1152/ajpgi.1985.248.2.G192. [DOI] [PubMed] [Google Scholar]
  18. Lautt W. W., Legare D. J. Adenosine modulation of hepatic arterial but not portal venous constriction induced by sympathetic nerves, norepinephrine, angiotensin, and vasopressin in the cat. Can J Physiol Pharmacol. 1986 Apr;64(4):449–454. doi: 10.1139/y86-072. [DOI] [PubMed] [Google Scholar]
  19. Lee S. S., Chilton E. L., Pak J. M. Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats. Hepatology. 1992 Jun;15(6):1107–1111. doi: 10.1002/hep.1840150622. [DOI] [PubMed] [Google Scholar]
  20. Llach J., Ginès P., Arroyo V., Salmerón J. M., Ginès A., Jiménez W., Gaya J., Rivera F., Rodés J. Effect of dipyridamole on kidney function in cirrhosis. Hepatology. 1993 Jan;17(1):59–64. [PubMed] [Google Scholar]
  21. Londos C., Cooper D. M., Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980 May;77(5):2551–2554. doi: 10.1073/pnas.77.5.2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mangione A., Imhoff T. E., Lee R. V., Shum L. Y., Jusko W. J. Pharmacokinetics of theophylline in hepatic disease. Chest. 1978 May;73(5):616–622. doi: 10.1378/chest.73.5.616. [DOI] [PubMed] [Google Scholar]
  23. Michaud P., Termet H., Agé C., Chassignolle J. Considérations sur quelques cas de chirurgie simultanée tricuspidienne et mitrale (rétrécissement et insuffisance) Ann Chir Thorac Cardiovasc. 1968 Apr;7(2):565–569. [PubMed] [Google Scholar]
  24. Milani L., Merkel C., Gatta A. Renal effects of aminophylline in hepatic cirrhosis. Eur J Clin Pharmacol. 1983;24(6):757–760. doi: 10.1007/BF00607083. [DOI] [PubMed] [Google Scholar]
  25. Moreau R., Champigneulle B., Gaudin C., Poo J. L., Kleber G., Bacq Y., Lebrec D. Effects of theophylline on hemodynamics and tissue oxygenation in patients with cirrhosis. J Hepatol. 1992 Jul;15(3):323–329. doi: 10.1016/0168-8278(92)90063-u. [DOI] [PubMed] [Google Scholar]
  26. Moreau R., Champigneulle B., Gaudin C., Poo J. L., Kleber G., Bacq Y., Lebrec D. Effects of theophylline on hemodynamics and tissue oxygenation in patients with cirrhosis. J Hepatol. 1992 Jul;15(3):323–329. doi: 10.1016/0168-8278(92)90063-u. [DOI] [PubMed] [Google Scholar]
  27. Moritoki H., Matsugi T., Takase H., Ueda H., Tanioka A. Evidence for the involvement of cyclic GMP in adenosine-induced, age-dependent vasodilatation. Br J Pharmacol. 1990 Jul;100(3):569–575. doi: 10.1111/j.1476-5381.1990.tb15848.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Murray B. M., Paller M. S. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action. Circ Res. 1985 Sep;57(3):424–431. doi: 10.1161/01.res.57.3.424. [DOI] [PubMed] [Google Scholar]
  29. Paul S., Kurunwune B., Biaggioni I. Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets. J Pharmacol Exp Ther. 1993 Nov;267(2):838–843. [PubMed] [Google Scholar]
  30. Pickard C. E., Stewart A. D., Hartley R., Lucock M. D. A rapid HPLC method for monitoring plasma levels of caffeine and theophylline using solid phase extraction columns. Ann Clin Biochem. 1986 Jul;23(Pt 4):440–446. doi: 10.1177/000456328602300410. [DOI] [PubMed] [Google Scholar]
  31. QUIMBY C. W., Jr, AVIADO D. M., Jr, SCHMIDT C. F. The effects of aminophylline and other xanthines on the pulmonary circulation. J Pharmacol Exp Ther. 1958 Mar;122(3):396–405. [PubMed] [Google Scholar]
  32. Schrier R. W., Arroyo V., Bernardi M., Epstein M., Henriksen J. H., Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988 Sep-Oct;8(5):1151–1157. doi: 10.1002/hep.1840080532. [DOI] [PubMed] [Google Scholar]
  33. Smits P., Lenders J. W., Thien T. Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther. 1990 Oct;48(4):410–418. doi: 10.1038/clpt.1990.169. [DOI] [PubMed] [Google Scholar]
  34. Um S. H., Nishida O., Tokubayashi M., Kimura F., Takimoto Y., Yoshioka H., Inque R., Kita T. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction. Hepatology. 1994 Jan;19(1):202–209. [PubMed] [Google Scholar]
  35. Utterback D. B., Staples E. D., White S. E., Hill J. A., Belardinelli L. Basis for the selective reduction of pulmonary vascular resistance in humans during infusion of adenosine. J Appl Physiol (1985) 1994 Feb;76(2):724–730. doi: 10.1152/jappl.1994.76.2.724. [DOI] [PubMed] [Google Scholar]
  36. Whittle B. J., Moncada S. Nitric oxide: the elusive mediator of the hyperdynamic circulation of cirrhosis? Hepatology. 1992 Oct;16(4):1089–1092. doi: 10.1002/hep.1840160437. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES